Finland: Kela and wellbeing services counties dispute over cancer medication reimbursement

A funding dispute between Finland's Social Insurance Institution (Kela) and regional wellbeing services counties has created uncertainty regarding the reimbursement of specialized cancer medications. While patients express concern over potential coverage gaps, researchers indicate that current legal frameworks should protect patient access to treatment. The situation remains unresolved as administrative responsibilities for medication costs are contested.